González-López N, Quintero E
*, Gimeno-García AZ, Bujanda L, Banales J, Cubiella J, Salve-Bouzo M, Herrero Rivas JM, Cid-Delgado E, Alvarez-Sanchez V, Ledo-Rodríguez A, de Castro-Parga ML, Fernández-Poceiro R, Sanromán-Álvarez L, Santiago García J, Herreros-de-Tejada A, Ocaña-Bombardo T, Balaguer F, Rodríguez-Soler M, Jover R, Ponce M, Álvarez C, Bessa X, Roncales MP, Sopeña F, Lanas A, Nicolás-Pérez D, Adrián-de Ganzo Z, Carrillo-Palau M, Gonzalez-Dávila E, Oncology Group of Asociación Española de Gastroenterología.
Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study). PLoS Med 2023; 20(10): e1004298 (Acceptat).